Department of Health and Human Services
Documentation of calls includes detail on the drug(s), patient characteristics, route of exposure, reported reasons for exposure, level of care received (e.g. admitted to critical care unit vs. treated and released), medical outcomes (e.g., death, no effect) and other more curated variables, such as...
https://www.accessdata.fda.gov/drugsatfda_docs/nda/2020/OSE%20Review_Hydroxychloroquine-Cholorquine%20-%2019May2020_Redacted.pdf